World J Crit Care Med
May 2022
Background: Critically ill patients are at risk of developing stress cardiomyopathy (SC) but can be under-recognized.
Aim: To describe a case series of patients with SC admitted to critical care units.
Methods: We conducted a retrospective observational study at a tertiary care teaching hospital.
Propofol is a first-line sedative agent in the intensive care unit (ICU) but may be associated with hypertriglyceridemia and pancreatitis. To date, the relationship between propofol-induced hypertriglyceridemia and pancreatitis, as well as clinician responses to propofol-induced hypertriglyceridemia, have not been comprehensively studied. To assess the incidence of hypertriglyceridemia and pancreatitis in patients receiving continuous propofol infusions in the ICU and to describe the association between hypertriglyceridemia and the use of nonpropofol continuous sedative infusions.
View Article and Find Full Text PDF